Use of activated coagulation factor VII for treating thrombolytic therapy-induced major bleedings

Details for Australian Patent Application No. 2002226386 (hide)

Owner Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors Skamira, Cord; Heusel, Gerhard; Stassen, Jean Marie; Wienen, Wolfgang

Agent Shelston IP

Pub. Number AU-B-2002226386

PCT Pub. Number WO02/49665

Priority 00128252.4 21.12.00 EP

Filing date 20 December 2001

Wipo publication date 1 July 2002

Acceptance publication date 22 December 2005

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

22 December 2005 Application Accepted

  Published as AU-B-2002226386

27 April 2006 Standard Patent Sealed

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002226387-DATA COMMUNICATION SYSTEM AND DATA CONVERSION DEVICE

2002226385-Induction of tolerance